PET imaging to monitor cancer therapy

Area of Science:

• Oncology
• Medical Imaging
• Molecular Biology

Background:

• Novel cancer therapeutics target complex pathways, making traditional response assessment difficult.
• Standard criteria based on anatomical changes often fail to predict treatment efficacy.
• Need for advanced imaging techniques to monitor treatment response at a molecular level.

Purpose of the Study:

• To review the application of Positron Emission Tomography (PET) in monitoring cancer therapy.
• To emphasize the role of PET in assessing key biological processes related to cancer.
• To provide an overview of PET imaging for evaluating treatment response.

Main Methods:

• Review of current literature on PET imaging in oncology.
• Focus on PET applications for assessing tumor metabolism, cell proliferation, angiogenesis, hypoxia, and receptor dynamics.
• Discussion of PET's ability to longitudinally assess biological processes.

Main Results:

• PET enables molecular-level monitoring of therapeutic response, complementing anatomical assessments.
• PET can longitudinally track specific biological processes indicative of treatment efficacy or resistance.
• Applications span various aspects of tumor biology, including metabolism, proliferation, and hypoxia.

Conclusions:

• PET imaging is a valuable tool for monitoring response to novel cancer therapeutics.
• Its ability to assess molecular and biological changes offers a more accurate prediction of treatment success.
• PET provides critical insights into tumor dynamics, guiding therapeutic strategies.